| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JNR.22775 |
| P698 | PubMed publication ID | 22002568 |
| P2093 | author name string | Ying Wang | |
| Hai Yan Zhang | |||
| Xi Can Tang | |||
| P2860 | cites work | Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors | Q24294213 |
| Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory | Q24645499 | ||
| Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease | Q24670696 | ||
| Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice | Q27312360 | ||
| The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
| Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide | Q28131750 | ||
| Interleukin-1beta enhances nucleotide-induced and alpha-secretase-dependent amyloid precursor protein processing in rat primary cortical neurons via up-regulation of the P2Y(2) receptor | Q28574838 | ||
| Development and Regulation of Dendritic Spine Synapses | Q29029261 | ||
| Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease | Q29617986 | ||
| Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo | Q29619108 | ||
| Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques | Q30486499 | ||
| Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice | Q33263907 | ||
| Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation | Q33740340 | ||
| Correlated memory defects and hippocampal dendritic spine loss after acute stress involve corticotropin-releasing hormone signaling | Q34059155 | ||
| Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease | Q34419295 | ||
| Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes | Q34452028 | ||
| Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease | Q34460984 | ||
| Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model | Q34797526 | ||
| Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L transgenic mice | Q35084882 | ||
| Emerging role for ERK as a key regulator of neuronal apoptosis | Q35895210 | ||
| Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model | Q36007461 | ||
| Neprilysin and amyloid beta peptide degradation | Q37130680 | ||
| Structure-neurotoxicity relationships of amyloid beta-protein oligomers | Q37329557 | ||
| Synaptotagmins in neurodegeneration | Q37640006 | ||
| l-3-n-Butylphthalide regulates amyloid precursor protein processing by PKC and MAPK pathways in SK-N-SH cells over-expressing wild type human APP695 | Q39640944 | ||
| ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons | Q39672952 | ||
| Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695. | Q40065891 | ||
| Involvement of M1-muscarinic acetylcholine receptors, protein kinase C and mitogen-activated protein kinase in the effect of huperzine A on secretory amyloid precursor protein-alpha | Q40147094 | ||
| Interleukin-1alpha stimulates non-amyloidogenic pathway by alpha-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase. | Q40275439 | ||
| P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing. | Q40444970 | ||
| Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-alpha in intracerebroventricular beta-amyloid-(1-40) infused rats and human embryonic kidney 293 Swedish mutant cells | Q40567243 | ||
| Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form | Q40634900 | ||
| Synaptic vesicle traffic: rush hour in the nerve terminal | Q40918904 | ||
| Cleavage of amyloid beta peptide during constitutive processing of its precursor | Q41852594 | ||
| Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy | Q42087146 | ||
| Proteolytic shedding of ST6Gal-I by BACE1 regulates the glycosylation and function of alpha4beta1 integrins | Q42748675 | ||
| Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice | Q42944835 | ||
| Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease | Q44060098 | ||
| Muscarine enhances soluble amyloid precursor protein secretion in human neuroblastoma SH-SY5Y by a pathway dependent on protein kinase C(alpha), src-tyrosine kinase and extracellular signal-regulated kinase but not phospholipase C. | Q44111144 | ||
| Dendrite and dendritic spine alterations in Alzheimer models | Q45099584 | ||
| Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons. | Q46350343 | ||
| Effects of huperzine A on secretion of nerve growth factor in cultured rat cortical astrocytes and neurite outgrowth in rat PC12 cells | Q46509880 | ||
| Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype | Q47711160 | ||
| Abeta oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms. | Q48103179 | ||
| The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging | Q48156883 | ||
| Regulation of amyloid precursor protein cleavage | Q48292877 | ||
| Huperzine A in rat plasma and CSF following intranasal administration | Q48301461 | ||
| Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. | Q48306292 | ||
| Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease | Q48400715 | ||
| Synaptotagmin: a calcium sensor on the synaptic vesicle surface | Q48480063 | ||
| Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment | Q48493675 | ||
| Low-density lipoprotein receptor-related protein promotes amyloid precursor protein trafficking to lipid rafts in the endocytic pathway. | Q50687332 | ||
| Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice. | Q51021977 | ||
| Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. | Q52560574 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 508-517 | |
| P577 | publication date | 2011-10-17 | |
| P1433 | published in | Journal of Neuroscience Research | Q6295654 |
| P1476 | title | Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice | |
| P478 | volume | 90 |
| Q48501744 | 3,4-dihydroxyphenylethanol attenuates spatio-cognitive deficits in an Alzheimer's disease mouse model: modulation of the molecular signals in neuronal survival-apoptotic programs |
| Q36308567 | A novel assay to determine acetylcholinesterase activity: The application potential for screening of drugs against Alzheimer's disease |
| Q38532717 | Brain Food for Alzheimer-Free Ageing: Focus on Herbal Medicines |
| Q27333843 | Diminished CRE-Induced Plasticity is Linked to Memory Deficits in Familial Alzheimer's Disease Mice |
| Q46330122 | Huperzine A alleviates neuroinflammation, oxidative stress and improves cognitive function after repetitive traumatic brain injury |
| Q92860670 | Huperzine A ameliorates obesity-related cognitive performance impairments involving neuronal insulin signaling pathway in mice |
| Q35646336 | Involvement of Intracellular and Mitochondrial Aβ in the Ameliorative Effects of Huperzine A against Oligomeric Aβ42-Induced Injury in Primary Rat Neurons |
| Q64096408 | Mutations of beta-amyloid precursor protein alter the consequence of Alzheimer's disease pathogenesis |
| Q37098664 | Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect |
| Q38162960 | Nature as a source of metabolites with cholinesterase-inhibitory activity: an approach to Alzheimer's disease treatment. |
| Q96306586 | Neurodegenerative pathways as targets for acquired epilepsy therapy development |
| Q38127470 | Novel disease-modifying therapeutics for the treatment of Alzheimer's disease. |
| Q37508249 | Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup |
| Q33963659 | RanBP9 overexpression accelerates loss of dendritic spines in a mouse model of Alzheimer's disease |
| Q89747430 | Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease |
| Q43245833 | The effects of huperzine A on gastrointestinal acetylcholinesterase activity and motility after single and multiple dosing in mice |
| Q36689057 | Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer's disease |
Search more.